Ovarian ablation in early breast cancer: overview of the randomised trials-Reference-Cited by-同舟云学术

Ovarian ablation in early breast cancer: overview of the randomised trials

Published:1996-11 Issue:9036 Volume:348 Page:1189-1196
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomised trials among 28,896 women.;N Engl J Med,1988

2. Treatment of early breast cancer, Vol 1: worldwide evidence 1985–1990.,1990

3. Systematic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women;Lancet,1992

4. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomised trials.;N Engl J Med,1995

5. Clinical trials in malignant disease: part II. Breast cancer: value of irradiation of the ovaries.;Paterson;J Fac Radiol,1959

Cited by 408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aromatase inhibitors: the journey from the state of the art to clinical open questions;Frontiers in Oncology;2023-12-22

2. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial;Journal of Clinical Oncology;2023-11-01

3. Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023;Bulletin du Cancer;2023-11

4. Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare;Geburtshilfe und Frauenheilkunde;2023-05-23

5. Role of Ovarian Suppression in Early Premenopausal Breast Cancer;Hematology/Oncology Clinics of North America;2023-02